Intel's turnaround is expected by 2027, but current market challenges and a lack of detailed plans make the stock ...

DoubleLine Income Solutions Fund shows mixed performance with 61% returns, but struggles with distribution sustainability.

The MM-II trial was carried out in partnership with Israel-based Moebius Medical and included 397 patients in the US, Europe, ...

One such example is Novo Nordisk (NYSE: NVO), the Denmark-based pharmaceutical leader whose shares are exchanging hands for ...

Dassault Systèmes is the world leader in mechanical computer-aided design software. Its high-end CAD software, Catia, is the industry standard in automotive, aerospace, and industrial products while ...

Hitachi Vantara, the data storage, infrastructure, and hybrid cloud management subsidiary of Hitachi, Ltd., is enhancing Virtual Storage Platform One (VSP One), introducing three guarantees for ...

Devo Technology, the security data analytics company, is partnering with Detecteam, the attack simulation and detection lifecycle management company, to solve critical challenges in detection ...

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

AbbVie is a popular stock with dividend investors for its high starting yield and continuous dividend increases. AbbVie is a ...

Many of her inquiries Tuesday focused on whether the Social Security case differs significantly from another Maryland case ...

Diabetics given the pill called orforglipron lost 16 pounds, or 7.9% of their body weight, over a 40-week period.

The results bring Eli Lilly's pill orforglipron one step closer to becoming a new, needle-free alternative in the booming ...